Clinical Trials Directory

Trials / Completed

CompletedNCT02744625

Physiologic Study of Cerebral Perfusion

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to measure cerebral perfusion using MRI in healthy subjects (with and without sedation) and in vasopressor-dependent patients

Conditions

Interventions

TypeNameDescription
DRUGHigher doses of vasopressor therapy for a MAP of 75 mmHg
DRUGLower doses of vasopressor therapy for a MAP of 65 mmHg
DRUGPropofol for light sedationPropofol for light sedation

Timeline

Start date
2016-04-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-04-20
Last updated
2017-03-30

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02744625. Inclusion in this directory is not an endorsement.

Physiologic Study of Cerebral Perfusion (NCT02744625) · Clinical Trials Directory